Management
Susan A. Wood, Ph.D., President and Chief Executive Officer
Dr. Wood has 14 years of experience championing innovative clinical solutions to the marketplace, from concept to revenue.
Dr. Wood most recently held the position of executive Vice President of Marketing and Technology for Vital Images, an innovative software company specializing in cardiovascular applications for advanced analysis software. Prior to Vital Images, Dr. Wood spent eight years at R2 Technology, most recently serving as VP of Marketing, where she championed the development, regulatory approval and commercial release of the first FDA approved (PMA) software product for the automatic detection of lung nodules in both diagnostic and screening chest CT examinations. She worked for three years at medical imaging software developer ISG Technologies (now Cedara Software), where she served as director of marketing for platform products and multimodality workstations.
Dr, Wood received her Ph.D. from the Johns Hopkins Medical Institutions, School of Hygiene and public health. Her Ph.D. work combined quantifying three-dimensional lung structure with changes in lung function using high-resolution CT imaging. She also holds a Master of Science degree in Biomedical Engineering from Duke University, and a Bachelor of Science in Engineering from the University of Maryland, College Park. She is considered a thought leader in the area of computer-aided detection and diagnosis.
Dr. Wood has been issued 6 patents in the field of computer-aided detection and quantitative imaging, authored numerous book chapters, peer-reviewed papers, abstracts, and served as an invited speaker at numerous conferences in the area of three-dimensional imaging of the thorax, quantitative imaging and computer-aided detection.
Michael Sims, Chairman
Currently the CEO of nSpire Medical Products, Mr. Sims is a leader in the pulmonary function test and clinical trials management business. He is a 20-year veteran of the medical imaging industry, having served most recently as CEO of IMADENT, an early stage dental imaging systems manufacturer, and CEO of Ultraguide, a surgical guidance device manufacturer. Prior to Ultraguide, Sims served as Vice President and head of the CT Products group at Marconi Medical Systems.
Dennis Wangeman, Partner
The Iowa First Capital Fund is a venture capital fund primarily focused on investing in Iowa businesses. The investments center on start-up and early stage companies; the Fund will invest in later stage opportunities as well. Currently, the Funds have 15 investments. The types of investments include gluten free product manufacturer, biotech drug discovery, ceramics manufacturer, biological navigation software developer and genetic animal health company.
Corridor Management Company, located in Cedar Rapids, Iowa, manages the Iowa First Capital Funds. The firm is composed of three partners, Jim Nikrant, Mark Drish and Dennis Wangeman. The individuals comprise various areas of experience ranging from marketing, legal to accounting and finance.
Joseph M. Reinhardt, Ph.D., Director and Co-Founder
Dr. Reinhardt is a Professor and Chair of Biomedical Engineering at The University of Iowa. Dr. Reinhardt's teaching and research interests are in the areas of image segmentation, registration, and medical image analysis and more recently in the area of lung mechanics as assessed from CT image data. Dr. Reinhardt was the chairman of the SPIE Medical Imaging Image Processing Conference from 2004 to 2008, is a senior member of the IEEE, and a fellow of the AIMBE. Read More >>
